Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted annual azithromycin for trachoma control in Vietnam
ACTRN12606000360516Phase 4Completed
- Sponsor
- International Trachoma Initiative
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of azithromycin, tetracycline and erythromycin in trachoma and Chlamydia trachomatis infection (3 arms), sponsored by International Trachoma Initiative. Primary endpoint: Prevalence and incidence of active trachoma and ocular Chlamydia trachomatis infection. Started Nov 2000; status: completed.
02
Drugs
azithromycintetracyclineerythromycin
03
Conditions
trachomaChlamydia trachomatis infection
Beyond the preview
Go deeper on ACTRN12606000360516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000360516.